510(k) K123713— IMMULISA ENHANCED CELIAC FUSION (TTG/DGP) IGA/IGG ANTIBODY ELISA

Substantially Equivalent

Immco Diagnostics, Inc.

Clearance details

Applicant: Immco Diagnostics, Inc.
Product code: Code MVM
Advisory panel: Immunology
Date received: 2012-12-04
Decision date: 2013-10-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Buffalo, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.